National List of Essential Medicines 2003

Publication date: 2003

Directorate General of Health Services Ministry of Health & Family Welfare Government of India lR;eso t;rs Contents List of Participants i Preface to National List of Essential Medicines 2003 ii Preface to National Essential Drugs List 1996 v List of Additions viii List of Omissions x List of Drug Movements Across Categories xi Therapeutic Categories xii List of Essential Medicines 1. Anaesthetics 1 1.1 General Anaesthetics and Oxygen 1 1.2 Local Anaesthetics 1 1.3 Preoperative Medication and Sedation for 1 Short Term Procedures 1.4 Postoperative Respiratory Stimulant 2 2. Analgesics, Antipyretics, Nonsteroidal Antiinflammatory 2 Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders 2.1 Non-Opioid Analgesics, Antipyretics and Nonsteroidal 2 Antiinflammatory Medicines 2.2 Opioid Analgesics 2 2.3 Medicines used to treat Gout 2 2.4 Disease Modifying Agents used in Rheumatoid Disorders 3 3. Antiallergics and Medicines used in Anaphylaxis 3 4. Antidotes and Other Substances used in Poisonings 3 4.1 Nonspecific 3 4.2 Specific 4 5. Anticonvulsants/Antiepileptics 4 6. Antiinfective Medicines 5 6.1 Anthelminthics 5 6.1.1 Intestinal Anthelminthics 5 6.1.2 Antifilarials 5 6.1.3 Antischistosomals and Antitrematode Medicines 5 6.2 Antibacterials 5 6.2.1 Beta Lactam Medicines 5 6.2.2 Other Antibacterials 6 6.2.3 Antileprosy Medicines 7 6.2.4 Antituberculosis Medicines 8 6.3 Antifungal Medicines 8 6.4 Antiviral Medicines 9 6.4.1 Antiherpes Medicines 9 6.4.2 Antiretroviral Medicines* 9 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors 9 6.4.2.2 Non-nucleoside Reverse Transcriptase Inhibitors 9 6.4.2.3 Protease Inhibitors 9 6.5 Antiprotozoal Medicines 10 6.5.1 Antiamoebic and Antigiardiasis Medicines 10 6.5.2 Antileishmaniasis Medicines 10 6.5.3 Antimalarial Medicines 10 6.5.3.1For Curative Treatment 10 6.5.3.2For Prophylaxis 11 6.5.4 Antipneumocystosis and Antitoxoplasmosis Medicines 11 7. Antimigraine Medicines 11 7.1 For Treatment of Acute Attack 11 7.2 For Prophylaxis 11 8. Antineoplastic, Immunosuppressives and Medicines 12 used in Palliative Care 8.1 Immunosuppressive Medicines 12 8.2 Cytotoxic Medicines 12 8.3 Hormones and Antihormones 13 8.4 Medicines used in Palliative Care 14 9. Antiparkinsonism Medicines 14 10. Medicines affecting the Blood 14 10.1 Antianemia Medicines 14 10.2 Medicines Affecting Coagulation 15 11. Blood Products and Plasma Substitutes 15 11.1 Plasma Substitutes 15 11.2 Plasma Fractions for Specific Use 15 12. Cardiovascular Medicines 16 12.1 Antianginal Medicines 16 12.2 Antiarrhythmic Medicines 16 12.3 Antihypertensive Medicines 17 12.4 Medicines used in Heart Failure 18 12.5 Antithrombotic Medicines 18 13. Dermatological Medicines (Topical) 18 13.1 Antifungal Medicines 18 13.2 Antiinfective Medicines 18 13.3 Antiinflammatory and Antipruritic Medicines 19 13.4 Astringent Medicines 19 13.5 Medicines Affecting Skin Differentiation and Proliferation 19 13.6 Scabicides and Pediculicides 19 14. Diagnostic Agents 19 14.1 Ophthalmic Medicines 19 14.2 Radiocontrast Media 20 15. Disinfectants and Antiseptics 20 15.1 Antiseptics 20 15.2 Disinfectants 21 16. Diuretics 21 17. Gastrointestinal Medicines 21 17.1 Antacids and other Antiulcer Medicines 21 17.2 Antiemetics 22 17.3 Antihaemorrhoidal Medicines 22 17.4 Antiinflammatory Medicines 22 17.5 Antispasmodic Medicines 22 17.6 Laxatives 22 17.7 Medicines used in Diarrhoea 23 17.7.1 Oral Rhydration Salts 23 17.7.2 Antidiarrhoeal Medicines 23 18. Hormones, other Endocrine Medicines and Contraceptives 23 18.1 Adrenal Hormones and Synthetic Substitutes 23 18.2 Androgens 23 18.3 Contraceptives 23 18.3.1 Hormonal Contraceptives 23 18.3.2 Intrauterine Devices 24 18.3.3 Barrier Methods 24 18.3.4 Non Hormonal Contraceptives 24 18.4 Estrogens 24 18.5 Antidiabetics and Hyperglycaemics 24 18.5.1 Insulins and Other Antidiabetic Agents 24 18.5.2 Hyperglycaemics 24 18.6 Ovulation Inducers 24 18.7 Progestogens 24 18.8 Thyroid and Antithyroid Medicines 25 19. Immunologicals 25 19.1 Diagnostic Agents 25 19.2 Sera and Immunoglobulins 25 19.3 Vaccines 25 19.3.1 For Universal Immunisation 25 19.3.2 For Specific Group of Individuals 26 20. Muscle Relaxants (peripherally acting) and Cholinesterase Inhibitors 26 21. Ophthalmological Preparations 26 21.1 Antiinfective Agents 26 21.2 Antiinflammatory Agents 27 21.3 Local Anaesthetics 27 21.4 Miotics and Antiglaucoma Medicines 27 21.5 Mydriatics 27 21.6 Ophthalmic Surgical Aids 27 22. Oxytocics and Antioxytocics 27 22.1 Oxytocics 27 22.2 Antioxytocics 27 23. Peritoneal Dialysis Solution 28 24. Psychotherapeutic Medicines 28 24.1 Medicines used in Psychotic Disorders 28 24.2 Medicines used in Mood Disorders 28 24.2.1 Medicines used in Depressive Disorders 28 24.2.2 Medicines used in Bipolar Disorders 28 24.3 Medicines used for Generalized Anxiety and Sleep Disorders 28 24.4 Medicines used for Obsessive Compulsive Disorders and 29 Panic Attacks 25. Medicines Acting on the Respiratory Tract 29 25.1 Antiasthmatic Medicines 29 25.2 Antitussives 29 26. Solutions correcting Water, Electrolyte, and Acid-Base Disturbances 29 26.1 Oral 29 26.2 Parenteral 30 26.3 Miscellaneous 30 27. Vitamins and Minerals 30 Index 31 List of Participants in the preparation of National List of Essential Medicines (i) Dr. S. D. Seth, Chairman (ii) Mr. Ashwini Kumar, Member Secretary (iii) Dr. Y. K. Gupta, Prof. of Pharmacology, AIIMS Member (iv) Dr. C. P. Singh, M. S., RML Hospital Member (v) Dr. Y. N. Rao, DDG(M) Member (vi) Dr. Sandeep Guleria, AIIMS Member (vii) Dr. P. L. Joshi, Addl. Project Director, NACO Member (viii) Dr. G. P. Sinha, Prof. of Medicine, Patna Medical College Member (ix) Dr. J. N. Pandey, HOD (Medicine), AIIMS Member (x) Dr. G. K. Biswas, Addl. DG (Stores) Member (xi) Dr. Nikita Gupta Kamal Member (xii) Dr. Rita Sood (co-opted) Member (xiii) Dr. R.N. Salhan (co-opted in April 2003) Member (xiv) Dr. Usha Gupta (co-opted in December 2002) Member (xv) Mr. Brijesh Regal, WHO Consultant in DCG(I) office Coordinator NATIONAL LIST OF ESSENTIAL MEDICINES 2003 i ii Preface to National List of Essential Medicines 2003 The review of National Essential Drugs List 1996, was due in the context of contemporary knowledge of the therapeutic products. An expert core committee was constituted by the Director General of Health Services in June 2002 for this purpose. The committee comprised of the following members: 1. Dr. Y. K. Gupta, Prof. of Pharmacology, AIIMS, New Delhi 2. Dr. C. P. Singh, Medical Suprintendant, RML Hospital, New Delhi 3. Dr. Y. N. Rao, DDG(M), DteGHS, MOHFW, New Delhi 4. Dr. Sandeep Guleria, AIIMS, New Delhi 5. Representative from ICMR, New Delhi 6. Representative from NACO, New Delhi 7. Dr. G. P. Sinha, Prof. of Medicines, Patna Medical College, Patna 8. Dr. J. N. Pandey, HOD (Medicines), AIIMS, New Delhi 9. Dr. G. K. Biswas, Addl. DG (Stores), DteGHS, MOHFW, New Delhi 10. Dr. Nikita Gupta Kamal, Ophthalmologist 11. Mr. Brijesh Regal, WHO Consultant in DCG(I) office 12. Mr. Ashwini Kumar, DCG(I), DteGHS, MOHFW, New Delhi Dr. S. D. Seth, Chair in Clinical Pharmacology, ICMR represented ICMR on the committee and was nominated by members to be the Chairman of the core committee. Dr. J. N. Pandey nominated Dr. Rita Sood, Addl. Prof. of Medicine, AIIMS to participate in the committee's delibrations. Dr. R. N. Salhan, Medical Suprintendant, RML Hospital contributed as member of the core committee, consequent to the retirement of Dr. C. P. Singh. Dr. P. L. Joshi was nominated by NACO as member of the committee. Dr. Usha Gupta, HOD Pharmacology, MAMC was coopted as member of the committee. After detailed delibrations in its first meeting, the committee agreed on the following criteria for identifying medicines for inclusion in the revised list: · Consideration of relevant disease burden in the country · Information on the efficacy, safety and comparative cost effectiveness of the products · Preference for single active compounds · Cost effectiveness in the context of cost of treatment · Available health delivery infrastructure (e.g. treatment facilities, training and experience of the available personnel; availability, financial resources; and environmental factors etc.) Addition of drugs required in emergency care/life threatening situations were also considered. The committee also decided to follow the principles and concepts of “Essential” drugs as enunciated by WHO, as was done for the 1996 list. Accordingly, the description of the list as 'Essential Medicines' List was adopted and includes three components: a definition, a description of the selection criteria and a description of the iii purpose for which such a list is developed, as follows: Definition: Essential medicines are those that satisfy the priority health care needs of the population. Selection criteria: Essential medicines are selected with due regard to disease prevalence, evidence on efficacy and safety, and comparative cost-effectiveness. Purpose: Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality. Evidently, the word “Essential” does not purport to convey that number of other drugs available in the market are non-essential. Several sub-committees of clinicians were formed to review the various sub-groups of medicines and core committee members coordinated the proceedings of one or more of these respective sub groups. Each of these sub-group members, and indeed all those who provided their professional inputs, were clearly explained about the fundamental doctorine of the “essential” medicine's description as stated above. The medicines that have finally been included in this list have gone through several intensive screenings by the expert group as well as by invited and consulted professionals. Cost of therapy was worked out especially in the context of already available therapies and keeping in view the drugs available for these categories in the WHO list of essential medicines. Essential Drugs List of various states and WHO Model Formulary (2002) were also referred during the review process. Medicines used by various national programmes and emergency care drugs etc. which were earlier identified by health care professionals in the context of drug policy, were also considered. A new section on medicines for HIV-AIDS has been included since it was non-existent in the 1996 list. Several new anti-cancer drugs have been added in the current list. Additional drugs find place in the revised list. The committee is of the opinion that since the word 'drug' is now globally considered to have a different (narcotic) connotation, it may be replaced with the word 'Medicine' a term which is now more widely used to describe therapeutic pharmaceutical substances. WHO has also renamed its list as Model List of Essential “Medicines”. Accordingly, the present list has been titled “National List of Essential Medicines”. The committee gratefully acknowledges the contributions made by the following experts: Dr. M. P. Sharma, Dr. Praveen Aggarwal, Dr. Nikhil Tandon, Dr. P. P. Kotwal, Dr. Arvind Kumar, Dr. Sunesh Kumar, Dr. Rakesh Yadav, Dr. S. K. Maulik, Dr. S. C. Tiwari, Dr. Ravi Saksena, Dr. Renu Saxena, Dr. Kaushal K. Verma. Categories of the medicines as classified in NEDL 1996 have been revised to harmonize with the latest “Sections” used by WHO Essential Medicines List. Although WHO has published two separate lists in its latest revision (core list and complementary iv list) the committee has taken a conscious decision to keep the core and complementary medicines together in the main list itself. The complementary medicines have been marked * and denote those medicines which may be needed when other medicines listed in the category are not readily available or they may be required in specific situations or locations for well founded reasons. The committee observed that critical care or emergency care medicines are many times perceived as “life saving drugs” though this is not a standard terminology in the context of overall use of medicinal products. It would be seen that the essential medicines list consists of medicines meant for the management of a wide variety of conditions ranging from symptomatic relief, public health care, management of infections as well as for “life threatening” - emergency situations & for critical care. An index of therapeutic categories has been included in the final version for ease of reference. The nomenclature of medicines has been made consistent with that used in India [e.g. Epinephrine has been changed to Adrenaline and first letters of names of the medicines have been made capital, as in Indian Pharmacopoeia (I.P.)]. It is felt that this list may be reviewed every two years to keep it relevant in the context of contemporary knowledge and drugs that keep appearing on the horizon. The committee gratefully acknowledges the support provided by WHO-India Country Office for the review process as well as for dissemination of this list. Preface to National Essential Drugs List 1996 1. The Ministry of Health, Government of India, is pleased to introduce the National Essential Drugs List for adoption in the country. The list is modelled on the WHO Essential Drugs List, and follows the general principles enunciated by WHO in the preparation of such lists. 2. In India, healthcare is provided by both Private and Public Sectors. It is the responsibility of the Public Sector to establish healthcare institutions accessible to all sections of the population in all parts of the country, to provide diagnostic and treatment facilities. However, the state has not accepted the responsibility of supplying the entire requirement of drugs to treat all the patients receiving treatment in state-funded institutions. At the levels of Central and State Governments, medicines are supplied free of cost or against token payment to the government employees, and free of cost to the weaker section of the population who avail of the treatment facilities provided by the Government through primary, secondary or tertiary levels of state healthcare institutions. Through different National Programmes for the control of diseases of high morbidity and endemicity drugs are also supplied to effect a cure to all patients who approach the treatment centres established under such programmes. 3. The National Essential Drugs List implies that the drugs included in it are adequate to meet the common contemporary health needs of the general population of the country and general obligation of the health administrators to ensure abundant availability of such drugs in the country. The drugs included in this list are generally safe and effective, and are approved by the Drugs Controller General, India, and are currently available at affordable prices to the general public. 4. The exclusion in the National List of any drug which is currently available and recommended by the physicians does not imply that they are less effective or unsuitable to the Indian patients. Their exclusion may have been influenced by one or more of the following factors-cost benefit ratio, dependence on imports or imported raw materials, indicated in the treatment of diseases not considered significant in the National context, insufficient experience with the drug in India, not approved for use in the specific indication by the Drugs Controller General, India, or for which no standard is approved under the Drugs & Cosmetics Act and Rules. The safety, efficacy and quality of the drugs currently available in India are according to the standards prescribed in India and the exclusion of any drug from this list does not mean that it is less effective in comparison to any alternative drug which has found its place in the list. 5. The national list is not intended as an imposition on the rights of state governments, government institutions, or private health care providers. It is meant to be used as a guideline to the concept of rational therapeutics and as an indicator of availability in the country. While the drugs selected are considered adequate to treat diseases common to most parts of the country, it is appreciated that specific regional requirements for drugs to treat diseases of local importance v vi may not be available in the National List, and in such instances it will be appropriate for the state health administration (adopting the National List) to include drugs as may be considered adequate to treat these diseases. 6. A committee of experts was constituted by the DGHS in February, 1996, to prepare the National Essential Drugs List. This committee selected a core group comprising of: Dr. P. Das Gupta Dr. S. D. Seth Dr. C. B. Sridhar Dr. M. R. Samuel Dr. J. N. Mohanty Dr. G. K. Biswas Dr. J. S. Bapna to prepare a preliminary list. The core group took note of the procurement of State Governments, different Central Government institutions (e.g. CGHS, ESIC, GMSD, etc.) and WHO Essential Drugs List. The tentative list was subjected to scrutiny for therapeutic efficacy, availability and cost-effectiveness by the core group in consultation with experts in different disciplines of medicine. The draft thwas finally adopted in the meeting of experts held on 4 April, 1996. 7. The list is intended to be a dynamic document, subject to change, with addition and/or deletions, as medical knowledge advances and new drugs become available at remunerative pricing. The list uses generic names for scientific clarity. 8. For convenience and ease of comparison, the same category numbers and headings have been used as in the WHO Model List (1995). However, only the names of the active bases have been used, avoiding the mention of salts or esters, e.g. morphine instead of morphine sulphate. The quantity mentioned in the strength of the dosage forms refers to the base unless by established practice or by pharmacopoeial standard it refers to the salt or the ester. The quality control standards are as in Indian Pharmacopoeia unless the drug is not included in I.P. 9. Drugs marked with an asterisk (*) are to be considered as complementary drugs, i.e. those that are used if the other drugs in the category are not available or they are required for specific patients, situations or locations for valid reasons. 10. The names of drugs are followed by the following letters to indicate their need at various levels of medical care: P Primary health care S Secondary health care T Tertiary health care U Universal 11. Although the drugs are listed by therapeutic categories, these are not necessarily meant to be used as prescribing guidelines. A drug that may deserve to be vii included in a particular category may not be found in the category as it may already be included in another category. Acknowledgement Our acknowledgements are due to Dr. Annapurna Rao, Dr. Ranjit Ray Chowdhury, Mr. Adeep Bagati, Dr. M. R. Samuel, Dr. S. D. Seth and Dr. J. S. Bapna for their valuable assistance and time to enable this first National Essential Drugs List to come out in such a short time. We are grateful to SEARO, WHO for their guidance and financial help for printing this list. Dr. P. Das Gupta Member-Secretary Expert Committee New Delhi April 22, 1996 A list of items not included in the 1996 edition but added in this edition is given below: 1. Adenosine 12.2 2. Alpha Interferon 8.2 3. Alprazolam 24.3 4. Artesunate 6.5.3.1 5. Azithromycin 6.2.2 6. Betaxolol Hydrochloride 21.4 7. Bretylium Tosylate 12.2 8. Bromocriptine Mesylate 9.0 9. Calcium Gluconate 4.2 10. Cefotaxime 6.2.1 11. Ceftadizidime 6.2.1 12. Ceftriaxone 6.2.1 13. Cefuroxime 6.2.1 14. Clarithromycin 6.2.2 15. Clomiphene Citrate 18.6 16. Clonidine Hydrochloride 12.3 17. Clotrimazole 6.3 18. Colchicine 2.3 19. Cryoprecipitate 11.2 20. Dexchlorpheniramine Maleate 3 21. Didanosine 6.4.2.1 22. Doxapram 1.4 23. Efavirenz 6.4.2.2 24. Esmolol 12.2 25. Fluconazole 6.3 26. Flumazenil 4.2 27. Flucytosine 6.3 28. Flutamide 8.2 29. Fresh Frozen Plasma 11.1 30. Gemcitabine Hydrochloride 8.2 31. Glucagon 18.5.2 32. Hormone Releasing IUD 18.3.1 33. Indinavir 6.4.2.3 34. Lamivudine + Nevirapine + Stavudine 6.4.2.1 35. Lamivudine + Zidovudine 6.4.2.1 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Name of the Drug Category viii 36. Lamivudine 6.4.2.1 37. Losartan Potassium 12.3 38. Magnesium Sulphate 5 39. Medroxy Progesterone Acetate 18.7 40. Methyl Cellulose 41. Metoprolol 12.1 42. Midazolam 1.3 43. Mifepristone 22.1 44. N/2 Saline 26.2 45. N/5 Saline 26.2 46. Nelfinavir 6.4.2.3 47. Nevirapine 6.4.2.2 48. Nitrazepam 24.3 49. Odansetron 8.4 50. Ofloxacin 6.2.4 51. Omeprazole 17.1 52. Paclitaxel 8.2 53. Physostigmine Salicylate 21.4 54. Platelet Rich Plasma 11.2 55. Potassium Chloride 26.2 56. Pyridostigmine Bromide 20 57. Pyrimethamine 6.5.3.1 58. Raloxifene 8.3 59. Ritonavir 6.4.2.3 60. Roxithromycin 6.2.2 61. Saquinavir 6.4.2.3 62. Sodium Bicarbonate 26.2 63. Stavudine 6.4.2.1 64. Sulphadiazine 6.2.2 65. Terazosin 12.3 66. Thiacetazone + Isoniazid 6.2.4 67. Trifluoperazine 24.1 68. Trimethoprim 6.5.4 69 Vancomycin Hydrochloride 6.2.2 70. Zidovudine 6.4.2.1 71. Zinc Oxide 13.4 Sl. No. Name of the Drug Category NATIONAL LIST OF ESSENTIAL MEDICINES 2003 ix A list of items included in the 1996 edition but not included in this edition is given below: 1. Biperiden 9 2. Ethnylestradiol + Norgestrel 18.3 3. Neomycin 6.2.2 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Name of the Drug Category x xi List of drug movements across categories 1. Acetyl Salicylic Acid 12.6 12.5 2. Acyclovir 6.5 6.4.1 3. Allopurinol 2.1 2.3 4. Amitriptyline 24.2 24.2.1 5. B.C.G Vaccine 19.3 19.3.1 6. Centchroman 18.3 18.3.4 7. D.P.T Vaccine 19.3 19.3.1 8. Diloxanide Furoate 6.4.1 6.5.1 9. Dobutamine 12.5 12.4 10. Dopamine 12.5 12.4 11. Ethinylestradiol + Levonorgestrel 18.3 18.3.1 12. Ethinylestradiol + Norethisterone 18.3 18.3.1 13. Fluoxetine 24.2 24.2.2 14. Furazolidone 17.7 17.7.2 15. Hepatitis B Vaccine 19.3 19.3.1 16. Imipramine 24.2 24.2.1 17. IUD Containing Copper 18.3 18.3.2 18. Loperamide 17.7 17.7.2 19. Measles Vaccine 19.3 19.3.1 20. Metronidazole 6.4.1 6.5.1 21. Oral Poliomyelitis Vaccine 19.3 19.3.1 22. Oral Rehydration Salts 17.7 17.7.1 23. Pentamidine 6.4.2 6.5.2 24. Praziquantel 6.1.1 6.1.3 25. Rabies Vaccine 19.3 19.3.2 26. Sodium Stibogluconate 6.4.2 6.5.2 27. Streptokinase 12.6 12.5 28. Sulphadoxine + Pyrimethamine 6.4.3 6.5.3.2 29. Tetanus Toxoid 19.3 19.3.2 30. Tinidazole 6.4.1 6.5.1 31. Urokinase 12.6 12.5 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Name of the Drug Category From To Therapeutic Categories 1. Anaesthetics 1 2. Analgesics, Antipyretics, Nonsteroidal Antiinflammatory 2 Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders. 3. Antiallergics and Medicines used in Anaphylaxis 3 4. Antidotes and Other Substances used in Poisonings 3 5. Anticonvulsants/Antiepileptics 4 6. Antiinfective Medicines 5 7. Antimigraine Medicines 11 8. Antineoplastic, Immunosuppressives and Medicines 12 used in Palliative Care 9. Antiparkinsonism Medicines 14 10. Medicines affecting the Blood 14 11. Blood Products and Plasma Substitutes 15 12. Cardiovascular Medicines 16 13. Dermatological Medicines (Topical) 18 14. Diagnostic Agents 19 15. Disinfectants and Antiseptics 20 16. Diuretics 21 17. Gastrointestinal Medicines 21 18. Hormones, other Endocrine Medicines and Contraceptives 23 19. Immunologicals 25 20. Muscle Relaxants (peripherally acting) and 26 Cholinesterase Inhibitors NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Therapeutic Category Page No. xii 21. Ophthalmological Preparations 26 22. Oxytocics and Antioxytocics 27 23. Peritoneal Dialysis Solution 28 24. Psychotherapeutic Medicines 28 25. Medicines Acting on the Respiratory Tract 29 26. Solutions correcting Water, Electrolyte, and 29 Acid-Base Disturbances 27. Vitamins and Minerals 30 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Therapeutic Category Page No. xiii NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 1 1. Anaesthetics 1.1 General Anaesthetics and Oxygen Ether, Anaesthetic S, T Inhalation Halothane S, T Inhalation Isoflurane* S, T Inhalation Ketamine U Injection 10 mg / ml Hydrochloride 50 mg / ml Nitrous Oxide U Inhalation Oxygen U Inhalation Thiopentone SodiumS, T Injection 0.5 g, 1 g powder 1.2 Local Anaesthetics Bupivacaine S, T Injection 0.25%, Hydrochloride 0.5% 0.5% + 7.5% Glucose Ethyl Chloride U Spray 1% Lignocaine U Topical Forms 2-5% Hydrochloride Injection 1-2% Spinal 5% + 7.5% Glucose Lignocaine U Injection 1%, 2% + Hydrochloride + Adrenaline Adrenaline 1:200,000 In vial 1.3 Preoperative Medication and Sedation for Short Term Procedures Atropine Sulphate U Injection 0.6 mg / ml Diazepam U Tablets 5 mg Injection 5 mg / ml * Complementary Midazolam U Injection 1 mg / ml 5 mg / ml Morphine Sulphate S, T Injection 10 mg / ml Promethazine U Syrup 5 mg / 5 ml 1.4 Postoperative Respiratory Stimulant Doxapram* T Injection 4 mg / ml 2. A n a l g e s i c s , A n t i p y r e t i c s , N o n s t e r o i d a l Antiinflammatory Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders. 2.1 Non-Opioid Analgesics, Antipyretics and Nonsteroidal Antiinflammatory Medicines Acetyl Salicylic Acid U Tablets 300 - 350 mg Diclofenac T Tablets 50 mg, 100 mg Injection 25 mg / ml Ibuprofen U Tablets 200 mg, 400 mg Paracetamol U Injection 150 mg / ml Syrup 125 mg / 5ml Tablets 500 mg 2.2 Opioid Analgesics Morphine S, T Injection 10 mg / ml Sulphate Tablets 10 mg Pentazocine S, T Tablets 25 mg, Injection 30 mg / ml Pethidine S, T Injection 50 mg / ml Hydrochloride 2.3 Medicines used to treat Gout Allopurinol S, T Tablets 100 mg Colchicine S, T Tablets 0.5 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 2 * Complementary 2.4 Disease Modifying Agents used in Rheumatoid Disorders Azathioprine S, T Tablets 50 mg Chloroquine S, T Tablets 150 mg Phosphate Methotrexate S, T Tablets 2.5 mg Sulfasalazine S, T Tablets 500 mg 3. Antiallergics and Medicines used in Anaphylaxis Adrenaline U Injection 1 mg / ml Bitartrate Chlorpheniramine U Tablets 4 mg Maleate Dexchlorpheniramine Syrup 0.5 mg / 5 ml Maleate Dexamethasone U Tablets 0.5 mg Injection 4 mg / ml Hydrocortisone Sodium Succinate U Injection 100 mg Pheniramine U Injection 22.75 mg / ml Maleate Prednisolone S Tablets 5 mg Promethazine U Tablets 10 mg, 25 mg Syrup 5 mg / 5 ml 4. Antidotes and Other Substances used in Poisonings 4.1 Nonspecific Activated Charcoal U Powder Atropine Sulphate U Injection 0.6 mg / ml NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 3 4.2 Specific Antisnake Venom U Injection Polyvalent Solution/ Lyophilyzed Polyvalent Serum Calcium Gluconate S,T Injection 100 mg / ml Desferrioxamine S, T Injection 500 mg Mesylate Dimercaprol S, T Injection in oil 50 mg / ml Flumazenil* T Injection 0.1 mg / ml Methylthioninium S, T Injection 10 mg / ml Chloride (Methylene blue) Naloxone S, T Injection 0.4 mg / ml Penicillamine S, T Tablets or Capsules 250 mg Pralidoxime S, T Injection 25 mg / ml Chloride (2-PAM) Sodium Nitrite S, T Injection 30 mg / ml Sodium Thio S, T Injection 250 mg/ ml 5. Anticonvulsants/Antiepileptics Carbamazepine U Tablets 100 mg, 200 mg Syrup 20 mg / ml Diazepam U Injection 5 mg / ml Magnesium T Injection 500 mg /ml Sulphate Phenobarbitone U Tablets 30 mg, 60 mg ST Injection 200 mg / ml Phenytoin Sodium U Capsules or Tablets 50 mg, 100 mg Syrup 25 mg / ml Injection 50 mg / ml sulphate NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 4 * Complementary Sodium Valproate U Tablets 200 mg, 500 mg Syrup 200 mg / 5 ml 6. Antiinfective Medicines 6.1 Anthelminthics 6.1.1 Intestinal Anthelminthics Albendazole U Tablets 400 mg Suspension 200 mg/ 5 ml Mebendazole U Tablets 100 mg Suspension 100 mg / 5 ml Niclosamide U Chewable Tablets 500 mg Pyrantel Pamoate U Tablets 250 mg Suspension 250 mg / 5 ml 6.1.2 Antifilarials Diethylcarbamazine U Tablets 50 mg Citrate 6.1.3 Antischistosomals and Antitrematode Medicines Praziquantel S, T Tablets 600 mg 6.2 Antibacterials 6.2.1 Beta Lactam Medicines Amoxicillin U Powder for suspension 125 mg / 5 ml Capsules 250 mg 500 mg Ampicillin U Capsules 250 mg, 500 mg Powder for suspension 125 mg / 5 ml Injection 500 mg Benzathine Benzylpenicillin U Injection 6 lacs, 12 lacs, 24 lacs units NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 5 Benzylpenicillin U Injection 5 lacs, 10 lacs units Cefotaxime* S, T Injection 125 mg, 250 mg, 500 mg Ceftazidime* S, T Injection 250mg, 1g Ceftriaxone* S, T Injection 250 mg, 1 g Cefuroxime* S, T Injection 250 mg, 750 mg Cloxacillin U Capsules 250 mg, 500 mg Injection 250 mg Liquid 125 mg / 5 ml Procaine Benzylpenicillin U Injection Crystalline penicillin (1 lac units) + Procaine penicillin (3 lacs units) 6.2.2 Other Antibacterials Amikacin S, T Injection 250 mg / 2 ml Azithromycin* S, T Capsules or Tablets 100 mg, 250 mg, 500 mg Suspension 100 mg / 5 ml Injection 500 mg Cephalexin U Syrup 125 mg / 5 ml Capsules 250 mg, 500 mg Clarithromycin* S, T Capsules 500 mg Chloramphenicol S, T Injection 1 g S, T Suspension 125 mg / 5 ml S, T Capsules, Tablets 250 mg, 500 mg Ciprofloxacin U Injection 200 mg / Hydrochloride 100 ml Tablets 250 mg, 500 mg * * NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 6 * Complementary Co-Trimoxazole U Tablets 40 + 200 mg (Trimethoprim + 80 + 400 mg Sulphamethoxazole) Suspension 40 + 200 mg / 5 ml Doxycycline U Capsules 100 mg Erythromycin U Syrup 125 mg / 5 ml Estolate Tablets 250 mg, 500 mg. Gentamicin U Injection 10 mg / ml 40 mg / ml Metronidazole U Tablets 200 mg, 400 mg Injection 500 mg / 100 ml Nalidixic Acid U Tablets 250 mg, 500 mg Nitrofurantoin U Tablets 100 mg Norfloxacin U Tablets 400 mg Roxithromycin* S, T Tablets 50 mg, 150 mg Sulphadiazine* S, T Tablets 500 mg Tetracycline U Tablets or Capsules 250 mg Vancomycin T Injection 500 mg, 1 g Hydrochloride* 6.2.3 Antileprosy Medicines Clofazimine S, T Capsules 50 mg, 100 mg Dapsone U Tablets 50 mg, 100 mg Rifampicin U Capsules or Tablets 150 mg, 300 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 7* Complementary 6.2.4 Antituberculosis Medicines Ethambutol U Tablets 200 mg, 400 mg, 600 mg, 800 mg Isoniazid U Tablets 50 mg, 100 mg, 300 mg Ofloxacin* S, T Tablets 100 mg, 200 mg Syrup 50 mg / 5 ml Pyrazinamide U Tablets 500 mg, 750 mg, 1000 mg, 1500 mg Rifampicin U Capsules/Tablets 50 mg, 150 mg, 300 mg, 450 mg Syrup 100 mg / 5 ml Streptomycin U Injection 0.75 g, 1 g Sulphate Thiacetazone + S, T Tablets 150 mg + Isoniazid 300 mg 6.3 Antifungal Medicines Amphotericin B S, T Injection 50 mg Clotrimazole U Pessaries 100 mg 200 mg Gel 2% Fluconazole S, T Capsules or Tablets 50 mg, 100 mg, 150 mg, 200 mg Flucytosine S, T Capsules 250 mg Griseofulvin U Capsules or Tablets 125 mg, 250 mg Ketoconazole S, T Tablets 200 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 8 * Complementary Nystatin U Tablets 500,000 IU Pessaries 100,000 IU 6.4 Antiviral Medicines 6.4.1 Antiherpes Medicines Acyclovir S, T Tablets 200 mg, 400 mg Injection 250 mg, 500 mg Suspension 400 mg / 5 ml 6.4.2 Antiretroviral Medicines* 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors Didanosine* S, T Tablets 250 mg 400 mg Lamivudine* S, T Tablets 150 mg Lamivudine + Nevirapine + Stavudine* S, T Tablets 150 mg + 200 mg + 30 mg Lamivudine + Zidovudine* S, T Tablets 150 mg + 300 mg Stavudine* S, T Capsules 15 mg, 30 mg, 40 mg Zidovudine* S, T Tablets 100 mg 300 mg 6.4.2.2 Non-nucleoside Reverse Transcriptase Inhibitors Efavirenz* S, T Capsules 200 mg 600 mg Nevirapine* S, T Capsules 200 mg Suspension 50 mg / 5 ml 6.4.2.3 Protease Inhibitors Indinavir* S, T Capsules 200 mg, 400 mg Nelfinavir* S, T Capsules 250 mg * NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 9* Complementary Ritonavir* S, T Capsules 100 mg Syrup 400 mg / ml Saquinavir* S, T Capsules 200 mg 6.5 Antiprotozoal Medicines 6.5.1 Antiamoebic and Antigiardiasis Medicines Diloxanide Furoate U Tablets 500 mg Metronidazole U Tablets 200 mg, 400 mg Injection 500 mg / 100 ml Tinidazole U Tablets 500 mg 6.5.2 Antileishmaniasis Medicines Amphotericin B S, T Injection 50 mg Pentamidine S, T Injection 200 mg Isothionate Sodium Stibogluconate S, T Injection 100 mg / ml 6.5.3 Antimalarial Medicines 6.5.3.1 For Curative Treatment Artesunate T Injection 60 mg Chloroquine U Tablets 150 mg Phosphate base Injection 40 mg / ml Syrup 50 mg / 5 ml Primaquine U Tablets 2.5 mg, 7.5 mg Pyrimethamine U Tablets 25 mg Quinine U Tablets 300 mg Sulphate S, T Injection 300 mg / ml Sulfadoxine + Pyrimethamine U Tablets 500 mg + 25 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 10 * Complementary 6.5.3.2 For Prophylaxis Chloroquine U Tablets 150 mg Phosphate base Syrup 50 mg / 5 ml 6.5.4 Antipneumocystosis and Antitoxoplasmosis Medicines Co-Trimoxazole U Tablets 40 + 200 mg (Trimethoprim + 80 + 400 mg Sulphamethoxazole) Suspension 40 + 200 mg / 5 ml Pentamidine S, T Injection 200 mg Isothionate Trimethoprim U Tablets 100 mg 7. Antimigraine Medicines 7.1 For Treatment of Acute Attack Acetyl Salicylic Acid U Tablets 300 - 350 mg Dihydroergotamine S, T Tablets 1 mg Paracetamol U Tablets 500 mg 7.2 For Prophylaxis Propranolol U Tablets 10 mg, 40 mg Hydrochloride NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 11 8. Antineoplastic, Immunosuppressives and Medicines used in Palliative Care 8.1 Immunosuppressive Medicines Azathioprine* T Tablets 50 mg Cyclosporine T Capsules 10 mg, 25 mg, 50 mg, 100 mg Concentrate for Injection 100 mg / ml 8.2 Cytotoxic Medicines Actinomycin D* T Injection 0.5 mg Alpha Interferon* T Injection 3 million IU Bleomycin* T Injection 15 mg Busulphan* T Tablets 2 mg Cisplatin* T Injection 10 mg / vial 50 mg / vial Cyclophosphamide* T Tablets 50 mg Injection 200 mg 500 mg Cytosine Arabinoside* T Injection 100 mg / vial 500 mg / vial 1000 mg / vial Danazol* T Capsules 50 mg, 100 mg Doxorubicin* T Injection 10 mg 50 mg Etoposide* T Capsules 100 mg Injection 100 mg / 5 ml NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 12 * Complementary Flutamide* T Tablet 250 mg 5-Fluorouracil* T Injection 250 mg / 5 ml Folinic Acid* T Injection 3 mg / ml Gemcitabine T Injection 200 mg Hydrochloride* 1 g L- Asparaginase* T Injection 10000 KU Melphalan* T Tablets 2 mg, 5 mg Mercaptopurine* T Tablets 50 mg, Injection 100 mg / ml Methotrexate* T Tablets 2.5 mg Injection 50 mg / ml Mitomycin-C* T Injection 10 mg Paclitaxel* T Injection 30 mg / 5 ml Procarbazine* T Capules 50 mg Vinblastine T Injection 10 mg Sulphate* Vincristine T Injection 1 mg / ml 8.3 Hormones and Antihormones Prednisolone* S, T Tablets 5 mg Injection 20 mg 25 mg (as sodium phosphate or succinate) Raloxifene* T Tablets 60 mg Tamoxifen T Tablets 10 mg, 20 mg Citrate* NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 13* Complementary 8.4 Medicines used in Palliative Care Morphine Sulphate* T Tablets 10 mg Ondansetron* S, T Tablets 4 mg, 8 mg Injection 2 mg / ml Syrup 2 mg / 5 ml 9. Antiparkinsonism Medicines Bromocriptine S, T Tablets 1.25 mg, Mesylate 2.5 mg Levodopa+ Carbidopa U Tablets 100 mg + 10 mg 250 mg + 25 mg 100 mg + 25 mg Trihexyphenidyl U Tablets 2 mg Hydrochloride 10. Medicines affecting the Blood 10.1 Antianemia Medicines Cyanocobalamin U Injection 1 mg / ml Ferrous Salt U Tablets Equivalent to 60 mg elemental iron Oral solution 25 mg elemental iron (as sulphate) / ml Folic Acid U Tablets 1 mg, 5 mg Iron Dextran S, T Injection 50 mg iron/ ml Pyridoxine U Tablets 5 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 14 * Complementary 10.2 Medicines Affecting Coagulation Acenocoumarol 4 mg Heparin Sodium S, T Injection 1000 IU / ml 5000 IU / ml Menadione Sodium Sulphite S, T Tablets 10 mg Protamine Sulphate S, T Injection 10 mg / ml Phytomenadione S, T Injection 10 mg / ml Warfarin S, T Tablets 5 mg Sodium 11. Blood Products and Plasma Substitutes 11.1 Plasma Substitutes Dextran-40 U Injection 10% Dextran-70 U Injection 6% Fresh Frozen Plasma* T Injection Hydroxyethyl Starch S, T Injection 6% (Hetastarch) Polygeline S, T Injection 3.5% 11.2 Plasma Fractions for Specific Use Albumin S, T Injection 5%, 20% Cryoprecipitate S, T Injection Factor VIII Concentrate* S, T Injection Dried Factor IX Complex (Coagulation Factors II,VII, IX, X) * S, T Tablets 1 mg, 2 mg, * S, T Injection Dried NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 15* Complementary Platelet Rich PlasmaS, T Injection 12. Cardiovascular Medicines 12.1 Antianginal Medicines Acetyl Salicylic Acid*U Tablets 75 mg, 100 mg 350 mg Diltiazem S, T Tablets 30 mg, 60 mg Glyceryl Trinitrate U Sublingual Tablets 0.5 mg Injection 5 mg / ml Isosorbide 5 Mononitrate/DinitrateU Tablets 10 mg, 20 mg Metoprolol* U Tablets 25 mg, 50 mg Injection 1 mg/ ml Propranolol U Tablets 10 mg, 40 mg Injection 1 mg / ml 12.2 Antiarrhythmic Medicines Adenosine* S, T Injection 3mg / ml Amiodarone S, T Tablets 100 mg, 200 mg Injection 150 mg Bretylium Tosylate* T Injection 1 mg, 2 mg 4 mg / ml Diltiazem S, T Tablets 30 mg, 60 mg Diltiazem T Injection 5 mg/ ml Esmolol* T Injection 10 mg / ml Isoprenaline T Injection 2 mg / ml Hydrochloride* Lignocaine S, T Injection 1%, 2% Hydrochloride Mexiletine S, T Capsules, 50 mg, Hydrochloride 150 mg Injection 25 mg / ml Procainamide T Tablets 250 mg Hydrochloride Injection 100 mg / ml * NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 16 * Complementary Quinidine T Tablets 100 mg Verapamil S, T Tablets 40 mg, 80 mg Injection 2.5 mg / ml 12.3 Antihypertensive Medicines Amlodipine U Tablets 2.5 mg, 5 mg, 10 mg Atenolol U Tablets 50 mg 100 mg Chlorthalidone* U Tablets 25 mg, 50 mg Clonidine S, T Tablets 100 mg Hydrochloride* 150 mg Enalapril U Tablets 2.5 mg, Maleate 5 mg, 10 mg Injection 1.25 mg / ml Losartan S, T Tablets 25 mg, 50 mg Potassium* Methyldopa U Tablets 250 mg Nifedipine S, T Capsules 5 mg, 10 mg Tablets 10 mg, 20 mg, Sustained release capsules 10 mg, or tablets 20 mg, Propranolol U Tablets 10 mg, 40 mg Sodium Nitroprusside Terazosin* S, T Tablets 1 mg, 2 mg, 5 mg * T Injection 50 mg/ 5 ml NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 17* Complementary 12.4 Medicines used in Heart Failure Digoxin S, T Tablets 0.25 mg Injection 0.25 mg / ml Elixir 0.05 mg / ml Dobutamine Dopamine S,T Injection 40 mg / ml Hydrochloride 12.5 Antithrombotic Medicines Acetyl Salicylic Acid U Tablets 75 mg, 100 mg Heparin S, T Injection 1000 IU / ml Sodium* 5000 IU / ml Streptokinase 750,000 IU Urokinase T Injection 500,000 IU / ml 10,00,000 IU / ml 13. Dermatological Medicines (Topical) 13.1 Antifungal Medicines Benzoic Acid + Salicylic Acid U Ointment or Cream 6% + 3% Miconazole U Ointment or Cream 2% 13.2 Antiinfective Medicines Acyclovir S, T Cream 5% Framycetin Sulphate U Cream 0.5% Methylrosanilinium Chloride (Gentian Violet) U Aqueous solution 0.5% * S, T Injection 50 mg / ml * S, T Injection 15,00,000 IU * NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 18 * Complementary Neomycin + Bacitracin U Ointment 5 mg + 500 IU Povidone Iodine U Solution or Ointment 5% Silver Nitrate U Lotion 10% Silver Sulphadiazine U Cream 1% 13.3 Antiinflammatory and Antipruritic Medicines Betamethasone U Cream / Ointment 0.05% Dipropionate Calamine U Lotion 13.4 Astringent Medicines Zinc Oxide U Dusting Powder 13.5 Medicines Affecting Skin Differentiation and Proliferation Coal Tar U Solution 5% Dithranol* T Ointment 0.1-2% Glycerin U Solution Salicylic Acid U Solution 5% 13.6 Scabicides and Pediculicides Benzyl Benzoate U Lotion 25% Gamma Benzene Hexachloride U Lotion 1% 14. Diagnostic Agents 14.1 Ophthalmic Medicines Fluorescein S, T Eye drops 1% NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 19* Complementary Lignocaine S, T Eye Drops 4% Tropicamide S, T Eye drops 1% 14.2 Radiocontrast Media Barium Sulphate S, T Suspension 100% w/v 250% w/v Calcium Ipodate S, T Injection 3 g Iopanoic Acid S, T Tablets 500 mg Meglumine Iothalamate S, T Injection 60% w/v (iodine = 280 mg / ml) Meglumine Iotroxate S, T Solution 5-8 g iodine in 100-250 ml Propyliodone S, T Oily, suspension 500- 600 mg / ml Sodium Iothalamate S, T Injection 70% w/v (Iodine = 420 mg / ml) Sodium S, T Injection 60% w/v Meglumine (Iodine Diatrizoate conc. = 292 mg / ml) 76% w/v (Iodine conc. = 370 mg / ml) 15. Disinfectants and Antiseptics 15.1 Antiseptics Acriflavin+Glycerin U Solution Benzoin Compound U Tincture NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 20 Cetrimide U Solution 20% (conc. for dilution) Chlorhexidine U Solution 5% (conc. for dilution) Ethyl Alcohol 70% U Solution Gentian Violet U Paint 0.5%, 1% Hydrogen Peroxide U Solution 6% Povidone Iodine U Solution 5%, 10% 15.2 Disinfectants Bleaching Powder U Powder Formaldehyde IP U Solution Glutaraldehyde S,T Solution 2% Potassium Permanganate U Crystals for solution 16. Diuretics Furosemide U Injection, 10 mg/ ml, Tablets 40 mg Hydrochlorothiazide U Tablets 25 mg, 50 mg Mannitol* U Injection 10%, 20% Spironolactone U Tablets 25 mg 17. Gastrointestinal Medicines 17.1 Antacids and other Antiulcer Medicines Aluminium U Tablet Hydroxide + Suspension Magnesium Hydroxide NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 21* Complementary Omeprazole U Capsules 10 mg, 20 mg, 40 mg Ranitidine U Tablets 150 mg, Hydrocholoride 300 mg Injection 25 mg / ml 17.2 Antiemetics Domperidone U Tablets 10 mg Syrup 1 mg / ml Metoclopramide U Tablets 10 mg Syrup 5 mg / ml Injection 5 mg / ml Prochlorperazine U Tablets 5 mg, 25 mg Promethazine U Tablets 10 mg, 25 mg Elixir or Syrup 5 mg / 5 ml Injection 25 mg / ml 17.3 Antihaemorrhoidal Medicines Local Anaesthetic, U Ointment /suppository Astringent and Antiinflammatory Medicines 17.4 Antiinflammatory Medicines Sulfasalazine T Tablets 500 mg 17.5 Antispasmodic Medicines Dicyclomine U Tablets 10 mg Hydrochloride Injection 10 mg / ml Hyoscine Butyl Bromide U Tablets or 10 mg Injection 20 mg / ml 17.6 Laxatives Bisacodyl U Tablets/ suppository 5 mg Isphaghula U Granules NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 22 17.7 Medicines used in Diarrhoea 17.7.1 Oral U Powder for solution As per IP Rehydration Salts 17.7.2 Antidiarrhoeal Medicines Furazolidone S, T Tablets 100 mg Syrup 25 mg / 5 ml Loperamide* S, T Capsules 2 mg (Contraindicated for paediatric use) 18. Hormones, other Endocrine Medicines and Contraceptives 18.1 Adrenal Hormones and Synthetic Substitutes Dexamethasone S, T Tablets 0.5 mg Injection 4 mg / ml Hydrocortisone U Injection 100 mg / ml Sodium Succinate Methylprednisolone S, T Injection 40 mg/ ml Prednisolone U Tablets 5 mg, 10 mg 18.2 Androgens Testosterone T Capsules 40 mg (as undecanoate) T Injection 25 mg / ml (as propionate) 18.3 Contraceptives 18.3.1 Hormonal Contraceptives Ethinylestradiol + U Tablets .03 mg + Levonorgesterol 0.15 mg Ethinylestradiol + Norethisterone U Tablets 0.035 mg + 1.0 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 23* Complementary Hormone Releasing IUD T Levonorgesterol Releasing IUD 18.3.2 Intrauterine Devices IUD containing Copper U 18.3.3 Barrier Methods Condoms U 18.3.4.Non Hormonal Contraceptives Centchroman U Tablets 30 mg 18.4 Estrogens Ethinylestradiol U Tablets 0.01 mg, 0.05 mg 18.5 Antidiabetics and Hyperglycaemics 18.5.1 Insulins and Other Antidiabetic Agents Glibenclamide U Tablets 2.5 mg, 5 mg Insulin Injection (Soluble) U Injection 40 IU / ml Intermediate Acting U Injection 40 IU / ml Insulin (Lente/NPH Insulin) Metformin U Tablets 500 mg 18.5.2 Hyperglycaemics Glucagon* T Injection 1 mg / ml 18.6 Ovulation Inducers Clomiphene T Tablets 25 mg, Citrate* 50 mg 100 mg 18.7 Progestogens Medroxy U Tablets 5 mg, 10 mg Progesterone Acetate Norethisterone U Tablets 5 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 24 * Complementary 18.8 Thyroid and Antithyroid Medicines Carbimazole S, T Tablets 5 mg, 10 mg Levothyroxine S, T Tablets 0.1 mg Iodine S, T Solution 8 mg / 5 ml 19. Immunologicals 19.1 Diagnostic Agents Tuberculin, Purified U Injection Protein Derivative 19.2 Sera and Immunoglobulins Anti-D S, T Injection 250 mg, 300 mg Immunoglobulin (Human) Antisnake Venom U Injection 10 ml Antitetanus Human U Injection 250 IU, 500 IU Immunoglobin Diphtheria Antitoxin S, T Injection 10,000 IU Rabies U Injection 150 IU / ml Immunoglobulin 19.3 Vaccines 19.3.1 For Universal Immunisation B.C.G Vaccine U Injection D.P.T Vaccine U Injection Hepatitis B Vaccine U Injection Measles Vaccine U Injection NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 25 Oral Poliomyelitis U Solution Vaccine (Live Attenuated) 19.3.2 For Specific Group of Individuals Rabies Vaccine U Injection Tetanus Toxoid U Injection 20. Muscle Relaxants (peripherally acting) and Cholinesterase Inhibitors Atracurium S, T Injection 10 mg / ml Besylate* Neostigmine S, T Tablets 15 mg Injection 0.5 mg/ ml Pancuronium S, T Injection 2 mg/ml Bromide Pyridostigmine S, T Tablet 60 mg Bromide Injection 1 mg / ml Succinyl Choline S, T Injection 50 mg/ ml Chloride 21. Ophthalmological Preparations 21.1 Antiinfective Agents Chloramphenicol U Drops/Ointment 0.4%, 1% Ciprofloxacin U Drops/Ointment 0.3% Hydrochloride Gentamicin U Drops 0.3% Miconazole U Drops 1% Povidone Iodine S, T Drops 0.6% Sulphacetamide U Drops 10%, Sodium 20%,30% Tetracycline U Ointment 1% Hydrochloride NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 26 * Complementary 21.2 Antiinflammatory Agents Prednisolone U Drops 0.1% Acetate Prednisolone U Drops 1% Sodium Phosphate Xylometazoline U Drops 0.05%, 0.1% 21.3 Local Anaesthetics Tetracaine U Drops 0.5% Hydrochloride 21.4 Miotics and Antiglaucoma Medicines Acetazolamide S, T Tablets 250 mg Betaxolol S, T Drops 0.25%, 0.5% Hydrochloride Physostigmine S, T Drops 0.25 % Salicylate* Pilocarpine S, T Drops 2%, 4% Timolol Maleate S, T Drops 0.25%, 0.5%, 21.5 Mydriatics Atropine Sulphate U Drops/Ointment 1% Homatropine U Drops 2% Phenylephrine U Drops 5% 21.6 Ophthalmic Surgical Aids Methyl Cellulose* T Injection 2% 22. Oxytocics and Antioxytocics 22.1 Oxytocics Methyl Ergometrine U Tablets 0.125 mg Injection 0.2 mg / ml Mifepristone T Tablets 200 mg Oxytocin S, T Injection 5 IU / ml, 10 IU / ml 22.2 Antioxytocics Isoxsuprine S, T Tablets 10 mg Hydrochloride Injection 5 mg / ml NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 27* Complementary Terbutaline S, T Tablets 2.5 mg Sulphate Injection 0.5 mg / ml 23. Peritoneal Dialysis Solution Intraperitoneal Dialysis Solution (of approximate composition) 24. Psychotherapeutic Medicines 24.1 Medicines used in Psychotic Disorders Chlorpromazine U Tablets 25 mg, Hydrochloride 50 mg, 100 mg Syrup 25 mg / 5 ml Injection 25 mg / ml Haloperidol S, T Tablets 1.5 mg, 5 mg, 10 mg Injection 5 mg / ml Trifluoperazine S, T Tablet 5 mg, 10 mg 24.2 Medicines used in Mood Disorders 24.2.1 Medicines used in Depressive Disorders Amitriptyline U Tablets 25 mg Fluoxetine U Capsules 20 mg Hydrochloride Imipramine U Tablets 25 mg, 75 mg 24.2.2 Medicines used in Bipolar Disorders Lithium Carbonate T Tablets 150 mg 24.3 Medicines used for Generalized Anxiety and Sleep Disorders Alprazolam U Tablets 0.25 mg, 0.5 mg Diazepam U Tablets 2 mg, 5 mg, 10 mg NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 28 Nitrazepam U Tablets 5 mg, 10 mg 24.4 Medicines used for Obsessive Compulsive Disorders and Panic Attacks Clomipramine S, T Tablets 10 mg, Hydrochloride 25 mg 25. Medicines Acting on the Respiratory Tract 25.1 Antiasthmatic Medicines Aminophylline U Injection 25 mg / ml Beclomethasone U Inhalation 50 mg, Dipropionate 250 mg/dose Hydrocortisone U Injection 100 mg, Sodium Succinate 200 mg, 400 mg Salbutamol U Tablets 2 mg, 4 mg Sulphate Syrup 2 mg / 5 ml Inhalation 100 mg / dose Theophylline U Tablets 100 mg, Compounds 200 mg 25.2 Antitussives Codeine U Tablets 10 mg Phosphate Syrup 15 mg / 5 ml Dextromethorphan U Tablets 30 mg 26. Solutions correcting Water, Electrolyte and Acid-Base Disturbances 26.1 Oral Oral Rehydration Salts U Powder for Solution As per IP 26.2 Parenteral NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form 29 Glucose U Injection 5% isotonic 50% hypertonic Glucose with U Injection 5% + 0.9% Sodium Chloride Normal Saline U Injection 0.9% N/2 Saline S, T Injection N/5 Saline S, T Injection Potassium Chloride U Injection 11.2% Sol. Ringer Lactate U Injection Sodium Bicarbonate U Injection 26.3 Miscellaneous Water for Injection U Injection 2 ml, 5 ml, 10 ml 27. Vitamins and Minerals Ascorbic Acid U Tablets 100 mg, 500 mg Calcium salts U Tablets 250 mg, 500 mg Multivitamins U Tablets (As per Schedule V) Nicotinamide U Tablets 50 mg Pyridoxine U Tablets 25 mg Riboflavine U Tablets 5 mg Thiamine U Tablets 100 mg Vitamin A U Tablets 5000 IU, Capsules 10,000 IU 50,000 IU Injection 50,000 IU / ml Vitamin D 3 (Ergocalciferol) S, T Capsules 0.25 mg, 1 mg 30 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Medicine Category Route of Administration/ Strengths Dosage Form NATIONAL LIST OF ESSENTIAL MEDICINES 2003 31 Index A 1. Acenocoumarol 15 2. Acetazolamide 27 3. Acetyl Salicylic Acid 2, 11, 16, 18 4. Acriflavin+Glycerin 20 5. Actinomycin D 12 6. Activated Charcoal 3 7. Acyclovir 9, 18 8. Adenosine 16 9. Adrenaline Bitartrate 3 10. Albendazole 5 11. Albumin 15 12. Allopurinol 2 13. Alpha Interferon 12 14. Alprazolam 28 15. Aluminium Hydroxide + Magnesium Hydroxide 21 16. Amikacin 6 17. Aminophylline 29 18. Amiodarone 16 19. Amitriptyline 28 20. Amlodipine 17 21. Amoxicillin 5 22. Amphotericin B 8, 10 23. Ampicillin 5 24. Antisnake Venom 4, 25 25. Anti-D Immunoglobulin (Human) 25 26. Antitetanus Human Immunoglobin 25 27. Artesunate 10 28. Ascorbic Acid 30 29. Atenolol 17 30. Atracurium Besylate 26 31. Atropine Sulphate 1, 3, 27, 32. Azathioprine 3, 12 33. Azithromycin 6 B 34. B.C.G Vaccine 25 35. Barium Sulphate 20 36. Beclomethasone Dipropionate 29 37. Benzathine Benzylpenicillin 5 38. Benzoic Acid + Salicylic Acid 18 39. Benzoin Compound 20 Sl. No. Medicine Page No. 40. Benzyl Benzoate 19 41. Benzylpenicillin 6 42. Betamethasone Dipropionate 19 43. Betaxolol Hydrochloride 27 44. Bisacodyl 22 45. Bleaching Powder 21 46. Bleomycin 12 47. Bretylium Tosylate 16 48. Bromocriptine Mesylate 14 49. Bupivacaine Hydrochloride 1 50. Busulphan 12 C 51. Calamine 19 52. Calcium Gluconate 4 53. Calcium Ipodate 20 54. Calcium salts 30 55. Carbamazepine 4 56. Carbimazole 25 57. Cefotaxime 6 58. Ceftazidime 6 59. Ceftriaxone 6 60. Cefuroxime 6 61. Centchroman 24 62. Cephalexin 6 63. Cetrimide 21 64. Chloramphenicol 6, 26 65. Chlorhexidine 21 66. Chloroquine Phosphate 3, 10, 11 67. Chlorpheniramine Maleate 3 68. Chlorpromazine Hydrochloride 28 69. Chlorthalidone 17 70. Ciprofloxacin Hydrochloride 6, 26 71. Cisplatin 12 72. Clarithromycin 6 73. Clofazimine 7 74. Clomiphene Citrate 24 75. Clomipramine Hydrochloride 29 76. Clonidine Hydrochloride 17 77. Clotrimazole 8 78. Cloxacillin 6 79. Coal Tar 19 80. Codeine Phosphate 29 81. Colchicine 2 32 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 82. Condoms 24 83. Co-Trimoxazole (Trimethoprim + Sulphamethoxazole) 7, 11 84. Cryoprecipitate 15 85. Cyanocobalamin 14 86. Cyclophosphamide 12 87. Cyclosporine 12 88. Cytosine Arabinoside 12 D 89. D.P.T Vaccine 25 90. Danazol 12 91. Dapsone 7 92. Desferrioxamine Mesylate 4 93. Dexamethasone 3, 23 94. Dexchlorpheniramine Maleate 3 95. Dextran-40 15 96. Dextran-70 15 97. Dextromethorphan 29 98. Diazepam 1, 4, 28 99. Diclofenac 2 100. Dicyclomine Hydrochloride 22 101. Didanosine 9 102. Diethylcarbamazine Citrate 5 103. Digoxin 18 104. Dihydroergotamine 11 105. Diloxanide Furoate 10 106. Diltiazem 16 107. Dimercaprol 4 108. Diphtheria Antitoxin 25 109. Dithranol 19 110. Dobutamine 18 111. Domperidone 22 112. Dopamine Hydrochloride 18 113. Doxapram 2 114. Doxorubicin 12 115. Doxycycline 7 E 116. Efavirenz 9 117. Enalapril Maleate 17 118. Erythromycin Estolate 7 119. Esmolol 16 33 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 120. Ethambutol 8 121. Ether, Anaesthetic 1 122. Ethinylestradiol + Levonorgesterol 23 123. Ethinylestradiol + Norethisterone 23 124. Ethinylestradiol 24 125. Ethyl Alcohol 70% 21 126. Ethyl Chloride 1 127. Etoposide 12 F 128. 5-Fluorouracil 13 129. Factor IX Complex (Coagulation Factors II,VII, IX, X)* 15 130. Factor VIII Concentrate 15 131. Ferrous Salt 14 132. Fluconazole 8 133. Flucytosine 8 134. Flumazenil 4 135. Fluorescein 19 136. Fluoxetine Hydrochloride 28 137. Flutamide 13 138. Folic Acid 14 139. Folinic Acid 13 140. Formaldehyde IP 21 141. Framycetin Sulphate 18 142. Fresh Frozen Plasma 15, 143. Furazolidone 23 144. Furosemide 21 G 145. Gamma Benzene Hexachloride 19 146. Gemcitabine Hydrochloride 13 147. Gentamicin 7, 26 148. Gentian Violet 21 149. Glibenclamide 24 150. Glucagon 24 151. Glucose with Sodium Chloride 30 152. Glucose 30 153. Glutaraldehyde 21 154. Glycerin 19 155. Glyceryl Trinitrate 16 156. Griseofulvin 8 H 34 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 157. Haloperidol 28 158. Halothane 1 159. Heparin Sodium 15, 18 160. Hepatitis B Vaccine 25 161. Homatropine 27 162. Hormone Releasing IUD 24 163. Hydrochlorothiazide 21 164. Hydrocortisone Sodium Succinate 3, 23, 29 165. Hydrogen Peroxide 21 166. Hydroxyethyl Starch (Hetastarch) 15 167. Hyoscine Butyl Bromide 22 I 168. Ibuprofen 2 169. Imipramine 28 170. Indinavir 9 171. Insulin Injection (Soluble) 24 172. Intermediate Acting Insulin (Lente/NPH Insulin) 24 173. Intraperitoneal Dialysis Solution (of approximate composition) 28 174. Iodine 25 175. Iopanoic Acid 20 176. Iron Dextran 14 177. Isoflurane 1 178. Isoniazid 8 179. Isoprenaline Hydrochloride 16 180. Isosorbide 5 Mononitrate/Dinitrate 16 181. Isoxsuprine Hydrochloride 27 182. Isphaghula 22 183. IUD containing Copper 24 K 184. Ketamine Hydrochloride 1 185. Ketoconazole 8 L 186. L- Asparaginase 13 187. Lamivudine + Zidovudine 9 188. Lamivudine +Nevirapine + Stavudine 9 189. Lamivudine 9 190. Levodopa+ Carbidopa 14 191. Levothyroxine 25 192. Lignocaine Hydrochloride + Adrenaline 1 35 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 193. Lignocaine Hydrochloride 1, 16 194. Lignocaine 20 195. Lithium Carbonate 28 196. Local Anaesthetic, Astringent and 22 Antiinflammatory Medicines 197. Loperamide (Contraindicated for paediatric use) 23 198. Losartan Potassium 17 M 199. Magnesium Sulphate 4 200. Mannitol 21 201. Measles Vaccine 25 202. Mebendazole 5 203. Medroxy Progesterone Acetate 24 204. Meglumine Iothalamate 20 205. Meglumine Iotroxate 20 206. Melphalan 13 207. Menadione Sodium Sulphite 15 208. Mercaptopurine 13 209. Metformin 24 210. Methotrexate 3, 13 211. Methyl Cellulose 27 212. Methyl Ergometrine 27 213. Methyldopa 17 214. Methylprednisolone 23 215. Methylrosanilinium Chloride (Gentian Violet) 18 216. Methylthioninium Chloride (Methylene blue) 4 217. Metoclopramide 22 218. Metoprolol 16 219. Metronidazole 7, 10 220. Mexiletine Hydrochloride 16 221. Miconazole 18, 26 222. Midazolam 2 223. Mifepristone 27 224. Mitomycin-C 13 225. Morphine Sulphate 2, 14 226. Multivitamins 30 N 227. N/2 Saline 30 228. N/5 Saline 30 229. Nalidixic Acid 7 230. Naloxone 4 231. Nelfinavir 9 36 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 232. Neomycin + Bacitracin 19 233. Neostigmine 26 234. Nevirapine 9 235. Niclosamide 5 236. Nicotinamide 30 237. Nifedipine 17 238. Nitrazepam 29 239. Nitrofurantoin 7 240. Nitrous Oxide 1 241. Norethisterone 24 242. Norfloxacin 7 243. Normal Saline 30 244. Nystatin 9 O 245. Ofloxacin 8 246. Omeprazole 22 247. Ondansetron 14 248. Oral Poliomyelitis Vaccine (Live Attenuated) 26 249. Oral Rehydration Salts 23, 29 250. Oxygen 1 251. Oxytocin 27 P 252. Paclitaxel 13 253. Pancuronium Bromide 26 254. Paracetamol 2, 11 255. Penicillamine 4 256. Pentamidine Isothionate 10, 11 257. Pentazocine 2 258. Pethidine Hydrochloride 2 259. Pheniramine Maleate 3 260. Phenobarbitone 4 261. Phenylephrine 27 262. Phenytoin Sodium 4 263. Physostigmine Salicylate 27 264. Phytomenadione 15 265. Pilocarpine 27 266. Platelet Rich Plasma 16 267. Polygeline 15 268. Potassium Chloride 30 269. Potassium Permanganate 21 270. Povidone Iodine 19, 21 37 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 271. Pralidoxime Chloride (2-PAM) 4 272. Praziquantel 5 273. Prednisolone 3, 13, 23 274. Prednisolone Acetate 27 275. Prednisolone Sodium Phosphate 27 276. Primaquine 10 277. Procainamide Hydrochloride 16 278. Procaine Benzylpenicillin 6 279. Procarbazine 13 280. Prochlorperazine 22 281. Promethazine 2, 3, 22 282. Propranolol Hydrochloride 11 283. Propranolol 16, 17 284. Propyliodone 20 285. Protamine Sulphate 15 286. Pyrantel Pamoate 5 287. Pyrazinamide 8 288. Pyridostigmine Bromide 26 289. Pyridoxine 14, 30 290. Pyrimethamine 10 Q 291. Quinidine 17 292. Quinine Sulphate 10 R 293. Rabies Immunoglobulin 25 294. Rabies Vaccine 26 295. Raloxifene 13 296. Ranitidine Hydrocholoride 22 297. Riboflavin 30 298. Rifampicin 7, 8 299. Ringer Lactate 30 300. Ritonavir 10 301. Roxithromycin 7 S 302. Salbutamol Sulphate 29 303. Salicylic Acid 19 304. Saquinavir 10 305. Silver Nitrate 19 306. Silver Sulphadiazine 19 38 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. 307 Sodium Meglumine Diatrizoate 20 308. Sodium Bicarbonate 30 309. Sodium Iothalamate 20 310. Sodium Nitrite 4 311. Sodium Nitroprusside* 17 312. Sodium Stibogluconate 10, 11 313. Sodium Thiosulphate 4 314. Sodium Valproate 5 315. Spironolactone 21 316. Stavudine 9 317. Streptokinase 18 318. Streptomycin Sulphate 8 319. Succinyl Choline Chloride 26 320. Sulfadoxine +Pyrimethamine 10 321. Sulfasalazine 3, 22 322. Sulphacetamide Sodium 26 323. Sulphadiazine 7 T 324. Tamoxifen Citrate 13 325. Terazosin 17 326. Terbutaline Sulphate 28 327. Testosterone 23 328. Tetanus Toxoid 26 329. Tetracaine Hydrochloride 27 330. Tetracycline Hydrochloride 26 331. Tetracycline 7 332. Theophylline Compounds 29 333. Thiacetazone + Isoniazid 8 334. Thiamine 30 335. Thiopentone Sodium 1 336. Timolol Maleate 27 337. Tinidazole 10 338. Trifluoperazine 28 339. Trihexyphenidyl Hydrochloride 14 340. Trimethoprim 11 341. Tropicamide 20 342. Tuberculin, Purified Protein Derivative 25 39 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 Sl. No. Medicine Page No. U 343. Urokinase 18 V 344. Vancomycin Hydrochloride 7 345. Verapamil 17 346. Vinblastine Sulphate 13 347. Vincristine 13 348. Vitamin A 30 349. Vitamin D3 (Ergocalciferol) 30 W 350. Warfarin Sodium 15 351. Water for Injection 30 X 352. Xylometazoline 27 Z 353. Zidovudine 9 354. Zinc Oxide 19 NATIONAL LIST OF ESSENTIAL MEDICINES 2003 40 Sl. No. Medicine Page No.

View the publication

You are currently offline. Some pages or content may fail to load.